FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

19496311000001100: Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1665451000001112 Sycrest 10mg sublingual tablets (Merck Sharp & Dohme Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1665461000001110 Sycrest 10mg sublingual tablets (Merck Sharp & Dohme Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1734101000001119 Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1734121000001114 Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66065901000001119 Sycrest 10mg sublingual tablets (Lundbeck Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
66066001000001111 Sycrest 10mg sublingual tablets (Lundbeck Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Is a Asenapine 10mg sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has active ingredient Asenapine true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Asenapine maleate true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Asenapine true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Is a Sycrest true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has basis of strength substance Asenapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has AMP True Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start